Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

14.05
Delayed Data
As of Feb 24
 -0.35 / -2.43%
Today’s Change
11.65
Today|||52-Week Range
37.20
+6.04%
Year-to-Date

Today’s Trading

Previous close14.40
Today’s open14.35
Day’s range13.85 - 14.35
Volume668,617
Average volume (3 months)1,328,938
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)-19.57%
Earnings growth (next 5 years)+15.02%
Revenue growth (last year)+44.36%
P/E ratioNM
Price/Sales3.58
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc-0.05-0.22%
DEPODepomed Inc-0.51-3.03%
LOXOLoxo Oncology Inc-0.21-0.50%
RGENRepligen Corp-0.27-0.83%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$0.16
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
J. Kevin Buchi
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts


Search for Jobs